Capivasertib, sold under the brand name Truqap, is an anti-cancer medication used for the treatment of breast cancer. It is taken by mouth. From Wikipedia
The targeted therapy, developed through decades of British research, offers significant clinical benefits for patients with hormone receptor-positive, HER2-negative advanced breast cancer.
